TBX3 and colorectal cancer: We applied ICEBERG to profile H3K4me3-marked regulatory regions, β-catenin and TBX3 targets in human colorectal cancer (CRC) cells, a context in which Wnt/β-catenin constitutes the main oncogenic driver and is subject of intense investigation in search of druggable mechanisms to treat disease (20–24).